Rheos Medicines
closedA biopharmaceutical company developing novel medicines that modulate metabolic pathways in immune cells to treat disease. Learn more
Launch date
–
Employees
Market cap
-
Enterprise valuation
$240—360m (Dealroom.co estimates Mar 2018.)
Cambridge Massachusetts (HQ)
Authorizing premium user...